STEPHANIE TRAN: Open Payments
NPI 1255892683 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,967 in 48 payments from 18 companies in 2025. Trend: 2023 $707 · 2024 $1,922 · 2025 $1,967
Food & beverage: $1,877Education: $90
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $529 |
| Janssen Biotech, Inc. | 6 | $269 |
| Journey Medical Corporation | 2 | $250 |
| Organon LLC | 2 | $173 |
| Regeneron Healthcare Solutions, Inc. | 5 | $139 |
| ABBVIE INC. | 5 | $99 |
| Lilly USA, LLC | 2 | $94 |
| UCB, Inc. | 3 | $89 |
| LEO Pharma Inc. | 3 | $82 |
| Incyte Corporation | 2 | $55 |
Products named: NEMLUVIO, TREMFYA, DUPIXENT, VTAMA, EMROSI, EBGLYSS, Bimzelx, SKYRIZI.
Industry payments across CA — which companies pay providers there.
